SSY Group Limited

SZSC:2005 Lagerbericht

Marktkapitalisierung: HK$11.2b

SSY Group Eigentümerschaft

Wer sind die Hauptanteilseigner und gab es Insider-Transaktionen?

Jüngste Insider-Transaktionen

SZSC:2005 Jüngste Insidertransaktionen von Unternehmen oder Einzelpersonen
DatumWertNameEntitätRolleAktienMaximaler Preis
15 Nov 24BuyHK$3,807,000China Pharmaceutical Company LimitedCompany1,000,000HK$3.81
14 Nov 24BuyHK$3,816,599China Pharmaceutical Company LimitedCompany1,000,000HK$3.82
30 Oct 24BuyHK$2,900,431China Pharmaceutical Company LimitedCompany780,000HK$3.72
29 Oct 24BuyHK$4,803,585China Pharmaceutical Company LimitedCompany1,280,000HK$3.75
21 Oct 24BuyHK$3,118,161China Pharmaceutical Company LimitedCompany800,000HK$3.90
14 Oct 24BuyHK$4,137,300China Pharmaceutical Company LimitedCompany1,000,000HK$4.14
08 Oct 24BuyHK$3,486,560China Pharmaceutical Company LimitedCompany800,000HK$4.36
04 Oct 24BuyHK$1,326,209China Pharmaceutical Company LimitedCompany300,000HK$4.42
25 Sep 24BuyHK$3,831,703China Pharmaceutical Company LimitedCompany1,000,000HK$3.83
24 Sep 24BuyHK$4,756,777Jiguang QuIndividual1,230,000HK$3.87
23 Sep 24BuyHK$3,141,582China Pharmaceutical Company LimitedCompany820,000HK$3.83
11 Sep 24BuyHK$9,496,757China Pharmaceutical Company LimitedCompany2,500,000HK$3.80
10 Sep 24BuyHK$3,849,600China Pharmaceutical Company LimitedCompany1,000,000HK$3.85
09 Sep 24BuyHK$5,002,920China Pharmaceutical Company LimitedCompany1,300,000HK$3.85
05 Sep 24BuyHK$8,597,376China Pharmaceutical Company LimitedCompany2,200,000HK$3.91
04 Sep 24BuyHK$3,906,499China Pharmaceutical Company LimitedCompany1,000,000HK$3.91
03 Sep 24BuyHK$3,919,497China Pharmaceutical Company LimitedCompany1,000,000HK$3.92
02 Sep 24BuyHK$7,746,206China Pharmaceutical Company LimitedCompany2,000,000HK$3.87
02 Sep 24BuyHK$1,524,441Jiguang QuIndividual400,000HK$3.81
30 Aug 24BuyHK$9,141,498China Pharmaceutical Company LimitedCompany2,350,000HK$3.89
21 Aug 24BuyHK$20,968,467Sichuan Kelun Industry Group CO., LTD.Company5,930,000HK$3.54
18 Apr 24BuyHK$4,675,199China Pharmaceutical Company LimitedCompany1,000,000HK$4.68
17 Apr 24BuyHK$3,810,403China Pharmaceutical Company LimitedCompany800,000HK$4.76
05 Apr 24BuyHK$2,523,165China Pharmaceutical Company LimitedCompany524,000HK$4.82
03 Apr 24BuyHK$7,513,495Jiguang QuIndividual1,500,000HK$5.01
02 Apr 24BuyHK$10,244,200China Pharmaceutical Company LimitedCompany2,000,000HK$5.12
28 Mar 24BuyHK$2,451,850Jiguang QuIndividual500,000HK$4.90
14 Dec 23BuyHK$7,394,103China Pharmaceutical Company LimitedCompany1,500,000HK$4.93
08 Dec 23BuyHK$2,129,042China Pharmaceutical Company LimitedCompany450,000HK$4.73
07 Dec 23BuyHK$3,289,488China Pharmaceutical Company LimitedCompany694,000HK$4.74
05 Dec 23BuyHK$4,741,002Jiguang QuIndividual1,000,000HK$4.74
04 Dec 23BuyHK$4,795,901China Pharmaceutical Company LimitedCompany1,000,000HK$4.80
24 Nov 23BuyHK$2,976,719China Pharmaceutical Company LimitedCompany600,000HK$4.96

Volumen des Insiderhandels

Insider-Käufe: 2005 Insider haben in den letzten 3 Monaten mehr Aktien gekauft als verkauft.

Aufschlüsselung der Eigentumsverhältnisse

Wie sieht die Eigentümerstruktur von 2005 aus?
Typ des EigentümersAnzahl der AktienEigentumsanteil in Prozent
Einzelne Insider311.054.00010,5 %
Einrichtungen568.200.98019,2 %
Allgemeine Öffentlichkeit595.100.40520,1 %
Private Unternehmen1.483.604.00050,2 %

Verwässerung von Anteilen: Die Aktionäre wurden im vergangenen Jahr nicht nennenswert verwässert.

Top-Aktionäre

Die Top 25 Aktionäre besitzen 79.5 % des Unternehmens
EigentümerschaftNameAktienAktueller WertVeränderung in %Portfolio %
28,9 %
China Pharmaceutical Company Limited
854.828.000HK$3.2b0,82 %keine Daten
21,3 %
Sichuan Kelun Industry Group CO., LTD.
628.776.000HK$2.4b3,63 %keine Daten
10 %
UBS Asset Management AG
295.795.721HK$1.1b0,09 %0,01 %
9,69 %
Jiguang Qu
286.638.000HK$1.1b0 %keine Daten
1,84 %
The Vanguard Group, Inc.
54.534.554HK$206.1m1,75 %keine Daten
1,13 %
Dimensional Fund Advisors LP
33.486.818HK$126.6m0 %keine Daten
0,83 %
Penghua Fund Management Co., Ltd.
24.486.000HK$92.6m0 %0,07 %
0,83 %
Xuejun Su
24.416.000HK$92.3m0 %keine Daten
0,77 %
BlackRock, Inc.
22.628.375HK$85.5m0,32 %keine Daten
0,75 %
Norges Bank Investment Management
22.159.717HK$83.8m0 %keine Daten
0,72 %
Bosera Asset Management Co., Ltd.
21.354.000HK$80.7m0 %0,05 %
0,65 %
UBS SDIC Fund Management Co., Ltd.
19.364.000HK$73.2m0 %0,21 %
0,4 %
Nordea Investment Management, AB
11.958.560HK$45.2m-0,02 %keine Daten
0,29 %
China Asset Management Co. Ltd.
8.656.729HK$32.7m-0,08 %keine Daten
0,23 %
E Fund Management Co., Ltd.
6.772.000HK$25.6m0 %keine Daten
0,21 %
Australian Super Pty Ltd
6.218.000HK$23.5m0 %keine Daten
0,2 %
GF Fund Management Co., Ltd.
6.060.000HK$22.9m0 %0,01 %
0,17 %
American Century Investment Management Inc
4.932.080HK$18.6m1,07 %keine Daten
0,15 %
State Street Global Advisors, Inc.
4.346.763HK$16.4m68,2 %keine Daten
0,14 %
Hwabao WP Fund Management Co., Ltd
4.106.000HK$15.5m0 %0,01 %
0,089 %
Border To Coast Pensions Partnership Limited
2.620.000HK$9.9m0 %0,01 %
0,079 %
China Southern Asset Management Co., Ltd.
2.324.000HK$8.8m0 %keine Daten
0,066 %
HuaAn Fund Management Company Ltd.
1.952.000HK$7.4m0 %keine Daten
0,058 %
Boston Partners Global Investors, Inc.
1.722.000HK$6.5m0 %keine Daten
0,052 %
China Merchants Fund Management Company Ltd.
1.528.000HK$5.8m0 %keine Daten